Funding news
Intermolecular logo

Intermolecular Raises $15.0M Series E

Recently funded · $15.0M Series eTechnology, Information and MediaUS

Get the full Intermolecular company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Intermolecular has secured $15.0 million in new investment capital from investors. The company operates as a trusted partner for materials innovation, focusing on the exploration, testing, and development of advanced materials. These materials are designed to revolutionize the next generation of electronics, aiming to make lives easier, more entertaining, and more productive for users worldwide.

For over 15 years, Intermolecular has leveraged its specialized team, robust methodologies, and high-quality data to drive impactful outcomes, create new market opportunities, and facilitate innovative product designs for its diverse customer base. As the Silicon Valley science hub of Merck KGaA, Darmstadt, Germany, the company is strategically positioned to push the boundaries of science and technology in the advanced materials sector. Intermolecular is an affiliate of Merck KGaA, Darmstadt, Germany, a global science and technology company with 57,000 employees worldwide, which is 70% privately owned and 30% publicly listed.

This significant funding round underscores investor confidence in Intermolecular's established expertise and its critical role in the development of advanced electronic materials. The newly raised capital is intended to support Intermolecular's ongoing growth initiatives, including expanding its operational capabilities, and to accelerate its research and development efforts. These investments will enable the company to further enhance its capabilities in materials exploration and testing, ensuring it remains at the forefront of innovation.

Looking ahead, Intermolecular plans to continue its mission of advancing digital living by delivering cutting-edge material solutions. The company aims to expand its impact on the electronics industry, driving further advancements that benefit consumers and businesses globally through revolutionary product designs.

Other United States companies recently funded

View all

Other recent Series e rounds

Companies that recently closed a Series e round.

#CompanyAmount
1
Chapter logo

Chapter

United States

$100.0M
2
Ivenix Infusion System logo

Ivenix Infusion System

United States

$50.0M
3
株式会社Schoo logo

株式会社Schoo

Japan

$2.1B
4
Nalu Medical, Inc. logo

Nalu Medical, Inc.

United States

$85.0M
5
Neocis logo

Neocis

United States

$20.0M